🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/01/2008 | 47,24 | 47,27 | 44,70 | 45,81 | -2,52% | 5,43% | 21.376.370 |
| 28/01/2008 | 45,57 | 47,09 | 44,96 | 46,99 | +3,06% | 4,67% | 24.323.975 |
| 25/01/2008 | 47,65 | 47,65 | 40,38 | 45,60 | -3,57% | 15,26% | 68.103.022 |
| 24/01/2008 | 48,08 | 49,33 | 45,28 | 47,29 | -1,49% | 8,43% | 42.295.498 |
| 23/01/2008 | 48,84 | 48,84 | 46,49 | 48,01 | -2,03% | 4,81% | 23.097.606 |
| 22/01/2008 | 49,14 | 50,05 | 46,85 | 49,00 | -3,69% | 6,50% | 30.991.456 |
| 18/01/2008 | 52,61 | 52,62 | 50,05 | 50,88 | -2,82% | 4,90% | 30.517.970 |
| 17/01/2008 | 55,19 | 55,73 | 51,98 | 52,36 | -5,96% | 6,79% | 31.305.751 |
| 16/01/2008 | 55,19 | 56,28 | 55,11 | 55,68 | +0,29% | 2,13% | 16.879.088 |
| 15/01/2008 | 56,23 | 56,87 | 55,40 | 55,52 | -2,68% | 2,61% | 19.071.714 |
| 14/01/2008 | 57,14 | 57,14 | 55,97 | 57,04 | -1,27% | 2,04% | 15.168.333 |
| 11/01/2008 | 57,28 | 58,38 | 57,25 | 57,78 | +0,13% | 1,97% | 9.895.426 |
| 10/01/2008 | 57,37 | 57,97 | 57,01 | 57,70 | -0,05% | 1,66% | 14.409.476 |
| 09/01/2008 | 56,97 | 58,09 | 56,44 | 57,73 | +1,41% | 2,90% | 17.504.220 |
| 08/01/2008 | 55,43 | 57,91 | 55,36 | 56,93 | +3,00% | 4,60% | 21.523.824 |
| 07/01/2008 | 54,48 | 55,74 | 54,34 | 55,27 | +1,88% | 2,57% | 11.874.783 |
| 04/01/2008 | 54,34 | 54,82 | 54,15 | 54,25 | -0,82% | 1,23% | 10.469.625 |
| 03/01/2008 | 54,82 | 55,29 | 54,48 | 54,69 | -0,09% | 1,46% | 8.831.810 |
| 02/01/2008 | 55,49 | 55,83 | 54,48 | 54,74 | -1,27% | 2,42% | 12.287.276 |
| 31/12/2007 | 55,68 | 56,10 | 55,44 | 55,45 | -1,02% | 1,18% | 8.486.599 |
| 28/12/2007 | 55,36 | 56,27 | 55,36 | 56,02 | +0,24% | 1,64% | 7.478.947 |
| 27/12/2007 | 56,40 | 56,49 | 55,78 | 55,89 | -1,43% | 1,25% | 7.397.622 |
| 26/12/2007 | 56,50 | 56,97 | 56,31 | 56,70 | -0,54% | 1,17% | 8.840.928 |
| 24/12/2007 | 56,36 | 57,21 | 56,36 | 57,00 | +1,00% | 1,52% | 4.478.209 |
| 21/12/2007 | 56,62 | 57,10 | 55,09 | 56,44 | +1,04% | 3,56% | 24.238.982 |
| 20/12/2007 | 57,14 | 57,21 | 55,65 | 55,86 | -1,35% | 2,74% | 12.240.326 |
| 19/12/2007 | 56,90 | 57,25 | 56,33 | 56,62 | -0,67% | 1,63% | 8.425.815 |
| 18/12/2007 | 57,06 | 57,28 | 56,60 | 57,00 | +0,42% | 1,19% | 10.275.011 |
| 17/12/2007 | 57,11 | 57,81 | 56,70 | 56,77 | -0,13% | 1,95% | 13.183.945 |
| 14/12/2007 | 56,77 | 57,25 | 56,42 | 56,84 | -0,37% | 1,46% | 9.676.918 |